| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/24/2005 | WO2004075923A3 Polymer-factor viii moiety conjugates |
| 02/24/2005 | WO2004073656A3 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 02/24/2005 | WO2004056386A3 Nucleic acids involved in blood-brain barrier control |
| 02/24/2005 | WO2004010997A8 Sustained-release tablet composition of pramipexole |
| 02/24/2005 | WO2004009064A8 Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means |
| 02/24/2005 | WO2003105661A3 Materials with both bioadhesive and biodegradable components |
| 02/24/2005 | WO2003093299A3 Insulin-associated peptides with effects on cerebral health |
| 02/24/2005 | WO2003061362A3 Methods and compositions for treating polycystic ovary syndrome |
| 02/24/2005 | WO2003059273A3 Antibody-avidin fusion proteins as cytotoxic drugs |
| 02/24/2005 | WO2003037400A3 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo |
| 02/24/2005 | US20050043481 Material consisting of at least a biodegradable polymer and cyclodextrins |
| 02/24/2005 | US20050043457 microfuidic osmotic pumps comprising flexible containers encapsulated by solutes, semipermeable membranes encapsulating the solutes, seals and bores; drug delivery devices |
| 02/24/2005 | US20050043399 Dimeric compounds and their use as anti-viral agents |
| 02/24/2005 | US20050043380 Composition for treatment of malignant tumors |
| 02/24/2005 | US20050043377 Thioflavin derivatives for use in the antemortem diagnosis of alzheimers disease and in vivo imaging and prevention of amyloid deposition |
| 02/24/2005 | US20050043375 Solid preparation containing single crystal form |
| 02/24/2005 | US20050043286 Use of an ascomycin for the treatment of blepharitis |
| 02/24/2005 | US20050043285 Formulation |
| 02/24/2005 | US20050043284 containing an anti-inflammatory and anti-allergic compound of the androstane series |
| 02/24/2005 | US20050043283 comprising a steroidal hormone (eg androgen) or anti-inflammatory agent (eg triamcinolone, hydrocortisone ); for cosmetics and dermatology |
| 02/24/2005 | US20050043271 Heparin-containing ophthalmic agent |
| 02/24/2005 | US20050043228 Glp-1 formulations with protracted time action |
| 02/24/2005 | US20050043225 Pharmaceutical formulation |
| 02/24/2005 | US20050043224 Administering to patient a pharmaceutical preparation comprising at least one chemoprotective inducing agent and a vehicle for delivering chemoprotective inducing agent to cells lining hair follicles, in an amount and for a time effective to reduce or prevent hair loss |
| 02/24/2005 | US20050043215 Complex drug delivery composition and method for treating cancer |
| 02/24/2005 | US20050042753 Drug delivery compositions |
| 02/24/2005 | US20050042680 Single chain antigen-binding polypeptides for polymer conjugation |
| 02/24/2005 | US20050042471 durable, stronger, more ergonomic, better-looking than purely stonecast products eg housewares & commercial ornamental articles |
| 02/24/2005 | US20050042304 Novel substituted benzimidazole dosage forms and method of using same |
| 02/24/2005 | US20050042303 Therapeutic protocols |
| 02/24/2005 | US20050042299 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 02/24/2005 | US20050042295 Anti-angiogenic compositions and methods of use |
| 02/24/2005 | US20050042294 Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
| 02/24/2005 | US20050042293 Mixture of hydrophobic drug and water soluble polymer; biodegradable insert |
| 02/24/2005 | US20050042280 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 02/24/2005 | US20050042279 Pharmaceutical formulation comprising more than 15% tamoxifen |
| 02/24/2005 | US20050042274 Compounds and compositions for delivering active agents |
| 02/24/2005 | US20050042273 Covalently linking PDGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound to form a Complex; diagnostic and therapeutic agent; improving pharmacokinetic properties |
| 02/24/2005 | US20050042268 Administering a hormone and penetration enhancer urea compound |
| 02/24/2005 | US20050042266 Cyanoacrylate compositions containing anti-microbial agent |
| 02/24/2005 | US20050042265 Composition for cutaneous repair and cicatrization comprising exclusively a true physical hydrogel of chitosan |
| 02/24/2005 | US20050042249 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 02/24/2005 | US20050042248 Mixture of polyol and insulation agent; gelation; dysmenorrhea |
| 02/24/2005 | US20050042241 Topical analgesic and/or antiinflammatory cream; bursitis, tendonitis; dimethyl sulfoxide and a mixture of pluronic gel and lecithin; allows the longer acting pain relievers ketoprofen and diphenhydramine to reach underlying inflamed tissues |
| 02/24/2005 | US20050042237 Method for administering a spill resistant pharmaceutical system |
| 02/24/2005 | US20050042236 Plant extract active as an immunostimulating agent |
| 02/24/2005 | US20050042218 Vaccines for treating and/or preventing cancer, infections, autoimmune diseases, and/or allergies |
| 02/24/2005 | US20050042216 Binding monoclonal, humanized, or fragment of antibody to human cell that expresses a protein; cancer |
| 02/24/2005 | US20050042201 Synergistic mixture of glycoprotein and angiogenesis inhibitor comprising angiostatin, thrombostatin, endostatin, interferon, interferon-inducible factor 10, platelet factor, and/or cyclooxygenase inhibitor; antitumor and anticarcinogenic agents |
| 02/24/2005 | US20050042194 Semi-solid delivery vehicle and pharmaceutical compositions |
| 02/24/2005 | US20050042182 Topical compositions of urea |
| 02/24/2005 | US20050042173 Pharmaceuticals, cosmetics or nutraceuticals with a bioadhesive and plasticizer on a biodegradable support for transdermal or transmucosal application |
| 02/24/2005 | US20050042171 Only once daily administration of an antispasmodic beta-2 adrenergic agonist and an antiinflammatory corticosteroid; inhalation; salmeterol xinafoate |
| 02/24/2005 | DE19828273B4 Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 02/24/2005 | CA2762015A1 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 02/24/2005 | CA2576060A1 Macrolides containing oil-in-water emulsions |
| 02/24/2005 | CA2535670A1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 02/24/2005 | CA2535554A1 Methods for reducing astringency |
| 02/24/2005 | CA2534897A1 Process of making flowable hemostatic compositions and devices containing such compositions |
| 02/24/2005 | CA2534895A1 Hemostatic compositions containing sterile thrombin |
| 02/24/2005 | CA2534629A1 Engineered proteases for affinity purification and processing of fusion proteins |
| 02/24/2005 | CA2534298A1 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 02/24/2005 | CA2534028A1 Liquid, aqueous pharmaceutical composition of factor vii polypeptides |
| 02/24/2005 | CA2532110A1 Process for the purification of non-ionic solvents for stabilized injectable pharmaceutical formulations |
| 02/24/2005 | CA2524737A1 Antibodies that immunospecifically bind to trail receptors |
| 02/23/2005 | EP1508601A1 Cyanoacrylate compositions containing anti-microbial agent |
| 02/23/2005 | EP1508332A1 Medicinal composition |
| 02/23/2005 | EP1508331A1 Method for preparing polymer micelle pharmaceutical preparation containing drug for injection |
| 02/23/2005 | EP1508330A1 Inhalation capsules |
| 02/23/2005 | EP1508329A1 Composition for an antifungal agent for suppressing fungal growth in an oral cavity |
| 02/23/2005 | EP1507874A2 Compositions and processes for inhibiting gene expression using polynucleotides |
| 02/23/2005 | EP1507860A2 Dynamic action reference tools |
| 02/23/2005 | EP1507859A2 Fusion proteins of humanized g250 specific antibodies and uses thereof |
| 02/23/2005 | EP1507851A1 Method for assembling sub units into capsoides |
| 02/23/2005 | EP1507826A2 Amelioration of the development of cataracts and other opthalmic diseases |
| 02/23/2005 | EP1507813A1 Fat binding using inter-polymer complex of glucosamine and polyacrylic acid |
| 02/23/2005 | EP1507804A1 Active carbohydrate containing protecting reagents for chemical modifications, their production and use |
| 02/23/2005 | EP1507794A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 02/23/2005 | EP1507781A2 Process for preparing maytansinol |
| 02/23/2005 | EP1507765A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 02/23/2005 | EP1507755A2 Novel monofunctional polyethylene glycol aldehydes |
| 02/23/2005 | EP1507562A1 Methods and compositions for radioimmunotherapy of brain and cns tumors |
| 02/23/2005 | EP1507559A1 Delivery of microparticle-conjugated drugs for inhibition of stenosis |
| 02/23/2005 | EP1507557A1 Methods and devices for targeting a site in a mammal and for removing species from a mammal |
| 02/23/2005 | EP1507556A2 Calicheamicin derivative-carrier conjugates |
| 02/23/2005 | EP1507550A1 Suicide tetramers comprising mhc class i and uses thereof |
| 02/23/2005 | EP1507538A1 Norethindrone sustained release formulations and methods associated therewith |
| 02/23/2005 | EP1507519A1 Medicament with delayed release of the active substance, containing 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol |
| 02/23/2005 | EP1507517A1 Microparticles bearing cells and active substances |
| 02/23/2005 | EP1507516A1 Co-grinding process for the preparation of a ternary composition |
| 02/23/2005 | EP1507515A2 Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 02/23/2005 | EP1507514A2 Controlled release compositions of estradiol metabolites |
| 02/23/2005 | EP1507455A1 Antimicrobial envelopes |
| 02/23/2005 | EP1313489B1 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome |
| 02/23/2005 | EP1311280A4 Cell internalized peptide-drug conjugates |
| 02/23/2005 | EP1207757B1 Ectoparasiticidal aqueous suspension formulations of spinosyns |
| 02/23/2005 | EP1175224B1 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy |
| 02/23/2005 | EP1119350B1 Rar antagonists as male anti-fertility agents |
| 02/23/2005 | EP0689454B2 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| 02/23/2005 | CN1585822A Polycistronic expression of antibodies |